Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

678 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic].
Ghrieb Z, Walter-Petrich A, Huang J, Chevret S, Montlahuc C, Resche-Rigon M, Kiladjian JJ, Allaoua S, Abdeljalil N. Ghrieb Z, et al. Among authors: chevret s. Therapie. 2024 Sep-Oct;79(5):519-531. doi: 10.1016/j.therap.2023.12.004. Epub 2024 Jan 17. Therapie. 2024. PMID: 38320894 Free article. French.
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Meyran D, Arfeuille C, Chevret S, Neven Q, Caye-Eude A, Lainey E, Petit A, Rialland F, Michel G, Plantaz D, Jubert C, Theron A, Gandemer V, Ouachée-Chardin M, Paillard C, Bruno B, Buchbinder N, Pochon C, Calvo C, Fahd M, Baruchel A, Cavé H, Dalle JH, Strullu M. Meyran D, et al. Among authors: chevret s. Haematologica. 2024 Sep 1;109(9):2908-2919. doi: 10.3324/haematol.2023.284103. Haematologica. 2024. PMID: 38385260 Free PMC article.
Impact of facial nerve resection in parotid cancer abutting the facial nerve without preoperative paralysis: A multicentric propensity score-based analysis.
Chatelet F, Chevret S, Fakhry N, Even C, Malard O, de Monès E, Saroul N, Mouawad F, de Boutray M, Mauvais O, Vergez S, Evrard D, Righini C, Schultz P, Baudouin R, Poissonnet G, Atallah S, Haroun F, Morinière S, Evrard C, Philouze P, Paasche A, Lesnik M, Lelonge Y, Herman P, Verillaud B; REFCOR members. Chatelet F, et al. Among authors: chevret s. Eur J Surg Oncol. 2024 Oct 10:108746. doi: 10.1016/j.ejso.2024.108746. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39424524 Free article.
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Villar S, Chevret S, Poire X, Joris M, Chevallier P, Bourhis JH, Forcade E, Chantepie S, Beauvais D, Raus N, Bay JO, Loschi M, Devillier R, Duléry R, Ceballos P, Rubio MT, Servais S, Nguyen S, Robin M. Villar S, et al. Among authors: chevret s. Bone Marrow Transplant. 2024 Jul;59(7):965-973. doi: 10.1038/s41409-024-02268-5. Epub 2024 Mar 21. Bone Marrow Transplant. 2024. PMID: 38514813
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group. Lê MP, et al. Among authors: chevret s. J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193. J Antimicrob Chemother. 2018. PMID: 29905808 Clinical Trial.
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies.
Dumont R, Lengliné E, Delorme C, Bru JP, Ansart S, Aslangul E, Kelley S, Cochat P, Chevret S, Diatta T. Dumont R, et al. Among authors: chevret s. Int J Technol Assess Health Care. 2024 Dec 9;40(1):e72. doi: 10.1017/S0266462324000552. Int J Technol Assess Health Care. 2024. PMID: 39651580 Review.
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia.
Tomowiak C, Poulain S, Nudel M, Feugier P, Herbaux C, Mahé B, Morel P, Aurran T, Tournilhac O, Leprêtre S, Assaad S, Villemagne B, Casasnovas O, Lhermitte A, Roos-Weil D, Torregrosa-Diaz J, Chevret S, Leblond V; on the behalf of the FILO group. Tomowiak C, et al. Among authors: chevret s. Ann Hematol. 2024 Nov 5. doi: 10.1007/s00277-024-06076-1. Online ahead of print. Ann Hematol. 2024. PMID: 39499299
678 results